Rytelo Disease Interactions
There is 1 disease interaction with Rytelo (imetelstat).
Imetelstat (applies to Rytelo) renal/hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Renal Dysfunction
Imetelstat has not been studied in patients with severe renal impairment or end-stage renal disease, or in patients with severe hepatic impairment. No clinically significant differences in exposure to imetelstat were observed in patients with mild to moderate renal or hepatic impairment.
Switch to professional interaction data
Rytelo drug interactions
There are 185 drug interactions with Rytelo (imetelstat).
Report options
More about Rytelo (imetelstat)
- Rytelo consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Decitabine
Decitabine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Luspatercept
Luspatercept (brand name Reblozyl) is used to treat anemia (low red blood cells) in certain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
